From Boardroom to Benchtop: Paul LaViolette Joins SVLS
This article was originally published in Start Up
Executive Summary
Paul LaViolette spent more than a decade at Boston Scientific where, among other things, he helped build the company into a cardiovascular powerhouse. LaViolette announced his retirement from BSC last year and after considering a number of opportunities, decided to join Boston-based SVLS as a venture partner. LaViolette enters venture investing at a challenging time, during which the industry will face what he calls "a Darwinian process with more operational pressure" at start-ups and a likely weeding out of many companies. In this interview, LaViolette describes how the venture world of 2008 feels a lot like Boston Scientific in 1993 -- a world of small, driven companies with huge operational challenges and huge opportunities.
You may also be interested in...
Medical Device Investing: Financing in an Economic Crisis
At FDC-Windhover's October IN3 East conference, we asked a distinguished panel of experienced venture capitalists to share their insights on the downturn in medtech venture investing. We invited our panelists to weigh in on the role of the current crisis in the second and third quarter slowdown in device investing and what it would mean going forward for a sector that had been so frothy just a short time earlier.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.